Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 21, Issue 11, Pages 1001-1016
Publisher
Informa UK Limited
Online
2017-09-19
DOI
10.1080/14728222.2017.1381087
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
- (2017) J A Menendez et al. Oncogenesis
- Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism
- (2016) Yanyan Cai et al. CANCER CELL
- Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis
- (2016) Camille Lehuédé et al. CANCER RESEARCH
- Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?
- (2016) Katherine Eason et al. CANCER RESEARCH
- 18 F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial
- (2016) Miguel Quintela-Fandino et al. CLINICAL CANCER RESEARCH
- Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
- (2016) A. Giro-Perafita et al. CLINICAL CANCER RESEARCH
- Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
- (2016) Simon Lord et al. CURRENT DRUG TARGETS
- Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors
- (2016) Maria Jose Bueno et al. CURRENT DRUG TARGETS
- Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
- (2016) Ramon Colomer et al. CURRENT DRUG TARGETS
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- Acetate as a Metabolic and Epigenetic Modifier of Cancer Therapy
- (2016) Diane M. Jaworski et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes
- (2016) Jean-Pierre Etchegaray et al. MOLECULAR CELL
- Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines
- (2016) Tanner K. Hill et al. MOLECULAR PHARMACEUTICS
- Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy
- (2016) Aarohi Bhargava-Shah et al. Nanomedicine
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
- (2016) A Strickaert et al. ONCOGENE
- Metformin and cancer: Quo vadis et cui bono?
- (2016) Javier A. Menendez et al. Oncotarget
- Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
- (2016) Xilan Yu et al. Oncotarget
- Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
- (2016) Elisabet Cuyàs et al. Oncotarget
- Repurposing metformin for cancer treatment: current clinical studies
- (2016) Young Kwang Chae et al. Oncotarget
- Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
- (2016) Gabriela Jiménez-Valerio et al. Cell Reports
- Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
- (2016) Elizabeth Allen et al. Cell Reports
- Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation
- (2016) Eoin McDonnell et al. Cell Reports
- Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
- (2015) Zachary T. Schug et al. CANCER CELL
- Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: Overview and application
- (2015) Yukie Yoshii et al. CANCER LETTERS
- Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
- (2015) M. Robertson-Tessi et al. CANCER RESEARCH
- Metabolic control of cancer cell stemness: Lessons from iPS cells
- (2015) Javier A Menendez CELL CYCLE
- Molecular Pathways: Fatty Acid Synthase
- (2015) S. F. Jones et al. CLINICAL CANCER RESEARCH
- Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
- (2015) Ming Luo et al. CURRENT PHARMACEUTICAL DESIGN
- The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs
- (2015) Javier Menendez CURRENT PHARMACEUTICAL DESIGN
- Crystal Structure and Substrate Specificity of Human Thioesterase 2
- (2015) Melissa K. Ritchie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
- (2015) R. Paulmurugan et al. MOLECULAR CANCER THERAPEUTICS
- Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
- (2015) Shany Koren et al. MOLECULAR CELL
- Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET
- (2015) Elena Hernández-Agudo et al. Molecular Oncology
- Toward understanding and exploiting tumor heterogeneity
- (2015) Ash A Alizadeh et al. NATURE MEDICINE
- Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
- (2015) Adriana Blancafort et al. PLoS One
- Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
- (2015) Camille Loubière et al. Oncotarget
- MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
- (2015) Richa Singh et al. Scientific Reports
- Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
- (2015) Takla Griss et al. PLOS BIOLOGY
- A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms
- (2015) Maria J. Bueno et al. EBioMedicine
- Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
- (2015) Richard Ventura et al. EBioMedicine
- Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes
- (2015) Sewha Kim et al. PLoS One
- Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer
- (2015) Yoon Yang Jung et al. PLoS One
- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment
- (2015) Javier A. Menendez et al. Oncotarget
- Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
- (2014) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
- (2014) Junqin Li et al. International Journal of Biological Sciences
- Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET
- (2014) D. Y. Lewis et al. JOURNAL OF NUCLEAR MEDICINE
- A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site
- (2014) Mary Ann Hardwicke et al. Nature Chemical Biology
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
- (2014) L Jiang et al. ONCOGENE
- Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
- (2014) Reema S. Wahdan-Alaswad et al. Hormones & Cancer
- Metabostemness: A New Cancer Hallmark
- (2014) Javier A. Menendez et al. Frontiers in Oncology
- Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor
- (2013) David A. Carlson et al. ACS Chemical Biology
- The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
- (2013) JAVIER MENENDEZ et al. CELL CYCLE
- Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
- (2013) BRUNA COROMINAS-FAJA et al. CELL CYCLE
- The mitochondrial H+-ATP synthase and the lipogenic switch
- (2013) Alejandro Vazquez-Martin et al. CELL CYCLE
- Differential Pharmacologic Properties of the Two C75 Enantiomers: (+)-C75 Is a Strong Anorectic Drug; (−)-C75 Has Antitumor Activity
- (2013) Kamil Makowski et al. CHIRALITY
- The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
- (2013) Laura M. DeFord-Watts et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade
- (2013) Bang-Bao Tao et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
- (2013) Mary Jo Cantoria et al. Metabolomics
- The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
- (2012) F Seguin et al. BRITISH JOURNAL OF CANCER
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- Challenges in targeting cancer metabolism for cancer therapy
- (2012) Ryuji Yamaguchi et al. EMBO REPORTS
- New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
- (2012) Carlos Turrado et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
- (2012) Madhuri Sankaranarayanapillai et al. MOLECULAR IMAGING AND BIOLOGY
- Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer
- (2012) P R Pandey et al. ONCOGENE
- Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
- (2012) Puspa R. Pandey et al. Recent Patents on Anti-Cancer Drug Discovery
- Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation
- (2012) Johan D. Oslob et al. ACS Medicinal Chemistry Letters
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Finding a Panacea among Combination Cancer Therapies
- (2011) R. Yamaguchi et al. CANCER RESEARCH
- Nuclear Factor-κB (NF-κB) Mediates a Protective Response in Cancer Cells Treated with Inhibitors of Fatty Acid Synthase
- (2011) Colleen R. M. Lemmon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Serum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosis
- (2011) Jorge Joven et al. JOURNAL OF CLINICAL VIROLOGY
- Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer
- (2010) G. Oliveras et al. Annals of the New York Academy of Sciences
- Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection
- (2010) Gerard Aragonès et al. BMC GASTROENTEROLOGY
- Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
- (2010) Puspa R. Pandey et al. BREAST CANCER RESEARCH AND TREATMENT
- De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
- (2010) E. Rysman et al. CANCER RESEARCH
- Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
- (2010) A. Vazquez-Martin et al. CELL PROLIFERATION
- Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
- (2010) A. Vazquez-Martin et al. CURRENT MOLECULAR MEDICINE
- Extracellular Fatty Acid Synthase: A Possible Surrogate Biomarker of Insulin Resistance
- (2010) J. M. Fernandez-Real et al. DIABETES
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
- (2010) Paul L. Nguyen et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic alterations and targeted therapies in prostate cancer
- (2010) Richard Flavin et al. JOURNAL OF PATHOLOGY
- Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
- (2010) Stefanie M. Ueda et al. Journal of Oncology
- Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives
- (2009) Javier A. Menendez BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Tumor heterogeneity: Causes and consequences
- (2009) Andriy Marusyk et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
- (2009) T. Puig et al. CLINICAL CANCER RESEARCH
- Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer
- (2009) J. A. Menendez et al. CLINICAL CHEMISTRY
- Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis
- (2009) Judit Marsillach et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Tumor suppressors and cell metabolism: a recipe for cancer growth
- (2009) R. G. Jones et al. GENES & DEVELOPMENT
- Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
- (2009) Toshiro Migita et al. JNCI-Journal of the National Cancer Institute
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid Synthase
- (2008) Cristina Oliveras-Ferraros et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- β-Lactam congeners of orlistat as inhibitors of fatty acid synthase
- (2008) Wei Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1
- (2008) E. Furuta et al. CANCER RESEARCH
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors
- (2008) H. Orita et al. CLINICAL CANCER RESEARCH
- Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-ketoacyl reductase reaction
- (2008) María Jesús Vázquez et al. FEBS Journal
- Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
- (2008) Marco A. Carvalho et al. INTERNATIONAL JOURNAL OF CANCER
- Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
- (2008) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
- (2008) Robyn D. Richardson et al. JOURNAL OF MEDICINAL CHEMISTRY
- A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
- (2008) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Gene expression in the human mammary epithelium during lactation: the milk fat globule transcriptome
- (2008) Patricia D. Maningat et al. PHYSIOLOGICAL GENOMICS
- The Crystal Structure of a Mammalian Fatty Acid Synthase
- (2008) T. Maier et al. SCIENCE
- BRCA1 and acetyl-CoA carboxylase: The metabolic syndrome of breast cancer
- (2007) Joan Brunet et al. MOLECULAR CARCINOGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now